• Core Scientific (CORZ) is trading at $29.00, up 4.4% in after-hours, recouping losses from a 4.7% decline during the regular session, which closed at $27.79.
  • The after-hours strength follows fresh analyst coverage, with BTIG reiterating a 'Buy' rating and a $33 price target, and Lucid Capital Markets initiating with a 'Buy' rating and a $40 price target.
  • An insider sale of 10,000 shares on June 22, 2026, by a Chief Legal and Administrative Officer was also reported today, adding to company-specific news.